wellbutrin retard tafla með breyttan losunarhraða 150 mg
glaxosmithkline pharma a/s - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 150 mg
wellbutrin retard tafla með breyttan losunarhraða 300 mg
glaxosmithkline pharma a/s - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 300 mg
darazíð tafla 20 mg/12,5 mg
actavis group ptc ehf. - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg/12,5 mg
metadon abcur (metadon novum abcur) tafla 40 mg
abcur ab* - methadonum hýdróklóríð - tafla - 40 mg
metadon abcur (metadon novum abcur) tafla 20 mg
abcur ab* - methadonum hýdróklóríð - tafla - 20 mg
nitroglycerin dak tungurótartafla 0,25 mg
orifarm healthcare a/s - glyceryli trinitras - tungurótartafla - 0,25 mg
nitroglycerin dak tungurótartafla 0,5 mg
orifarm healthcare a/s - glyceryli trinitras - tungurótartafla - 0,5 mg
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tafil tafla 0,25 mg
upjohn eesv - alprazolamum inn - tafla - 0,25 mg
tafil tafla 0,5 mg
upjohn eesv - alprazolamum inn - tafla - 0,5 mg